Name: Latest research reports of Divi's Laboratories Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 5
Author: Geojit BNP Paribas

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	30 Jul 2025	Divi's Laboratories	Consensus Share Price Target	6710.00	6459.59	-	-3.73	hold	pdf Detailed Estimates
	25 Aug 2022	Divi's Laboratories	Geojit BNP Paribas Target	6710.00	4006.00	3587.50 (87.04%)		Buy	pdf post cache	Broker Report DIVI' S LAB Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	16 Aug 2022	Divi's Laboratories	ICICI Securities Limited Target	6710.00	4173.00	3726.20 (80.08%)		Accumulate	pdf post cache	Broker Report Recovery in API; margins hit ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q1FY23 performance was a mixed bag with revenue ahead of our estimates while margin was lower. pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2022	Divi's Laboratories	Prabhudas Lilladhar Target	6710.00	4140.00	3732.00 (79.80%)		Accumulate	pdf post cache	Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2022	Divi's Laboratories	BOB Capital Markets Ltd.	6710.00	4250.00	3726.20 (80.08%)		Hold	pdf post cache	Broker Report Divi's Labs (HOLD): No respite in sight for margins BOB Capital Markets Ltd. Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below pdf Copy Link Share on Share on Share on Share on Alert
	12 Aug 2022	Divi's Laboratories	ICICI Direct Target	6710.00	4315.00	3726.20 (80.08%)		Buy	pdf post cache	Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	26 May 2022	Divi's Laboratories	SMC online	6710.00		3514.70 (90.91%)		Results Update	pdf post cache	Broker Report Divis Laboratories Limited SMC online pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2022	Divi's Laboratories	ICICI Direct	6710.00	4655.00	3661.70 (83.25%)		Buy	pdf post cache	Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2022	Divi's Laboratories	ICICI Securities Limited Reco Target	6710.00	4361.00	3897.90 (72.14%)		Accumulate	pdf post cache	Broker Report Beat on all fronts ICICI Securities Limited The strong growth was led by the custom synthesis division most likely due to higher than expected revenues from Molnupiravir. API segment continues its weak performance due to intense pricing pressures. pdf Copy Link Share on Share on Share on Share on Alert
	23 May 2022	Divi's Laboratories	BOB Capital Markets Ltd. Target	6710.00	4250.00	3519.35 (90.66%)	Target met	Hold	pdf post cache	Broker Report Divi's Labs (HOLD): Strong all-round beat but growth unsustainable cut to HOLD BOB Capital Markets Ltd. Robust standalone Q4 revenue/EBITDA growth of 45%/57% YoY, ahead of consensus by 11%/17% pdf Copy Link Share on Share on Share on Share on Alert
	23 May 2022	Divi's Laboratories	Motilal Oswal Target	6710.00	4480.00	3661.70 (83.25%)		Buy	pdf post cache	Broker Report Ends FY22 on a strong note Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
more loading

45.38% Gain from 52W Low

Divi's Laboratories Ltd. share price target

Divi's Laboratories Ltd. has an average share price target of 5824.57. The consensus estimate represents a downside of -13.20% from the last price of 6710. View 9 reports from 7 analysts offering long-term price targets for Divi's Laboratories Ltd..

DIVI' S LAB

Recovery in API; margins hit

DIVI'S LABORATORIES

Divi's Labs (HOLD): No respite in sight for margins

Divi's Laboratories

Divis Laboratories Limited

Divi's Laboratories

Beat on all fronts

Divi's Labs (HOLD): Strong all-round beat but growth unsustainable cut to HOLD

Ends FY22 on a strong note

Advisor Screeners